The assessment of risk from exposure to environmental air pollutants is complex, and involves the disciplines of epidemiology, animal toxicology, and human inhalation studies. Controlled, quantitative studies of exposed humans help determine health-related effects that result from breathing the atmosphere. The major unique feature of the clinical study is the ability to select, control, and quantify pollutant exposures of subjects of known clinical status, and determine their effects under ideal experimental conditions. The choice of outcomes to be assessed in human clinical studies can be guided by both scientific and practical considerations, but the diversity of human responses and responsiveness must be considered. Subjects considered to be among the most susceptible include those with asthma, chronic obstructive lung disease, and cardiovascular disease. New experimental approaches include exposures to concentrated ambient air particles, diesel engine exhaust, combustion products from smoking machines, and experimental model particles. Future investigations of the health effects of air pollution will benefit from collaborative efforts among the disciplines of epidemiology, animal toxicology, and human clinical studies.
The assessment of risk for acute and/or chronic inhalation of low-level environmental air pollutants is complex. Typically, the database for risk assessment arises from three separate investigational approaches: epidemiology, animal toxicology, and human inhalation studies. Carefully controlled quantitative studies of exposed humans utilize laboratory atmospheric conditions, considered relevant to outdoor pollutant levels, or concentrated particles from the ambient air, and document health-related effects that result from breathing the atmosphere. Advantage is taken of the highly controlled environment to identify responses to individual pollutants and characterize exposure-response relationships. In addition, the controlled environment provides an opportunity to study interaction among pollutants per se In this article we examine the exposure methodologies and study design issues essential for performance of controlled clinical studies.
Subsequently, we focus on the investigative tools available to evaluate respiratory, cardiovascular, and pharmacokinetic outcomes. Finally, our current understanding of responses of susceptible populations as determined by the clinical study is reviewed.
Experimental Design and Methods
Controlled human exposure studies of inhaled gases and particles, especially those designed to evaluate short-term effects of airborne pollutants, have been performed in multiple laboratories over the past decade. The major unique feature of the dinical study is the ability to select, control, and quantify pollutant exposures of subjects of known clinical status and determine their effects on cardiopulmonary performance under ideal conditions for conducting physiologic evaluations.
Typically, modern clinical studies use exposures to single pollutants or simple pollutant mixtures, exposure durations of 0.5-8 hr, and a double-blind, crossover design. Exposures are often conducted in environmentally controlled chambers m3 volume) with a single passage of the pollutant(s). Physiologic responses may include lung function, or cardiac rate, rhythm, and variability. Techniques used to detect potential biomarkers include bronchoscopy, nasal lavage, or sputum induction. Techniques are also available to measure airway size and mucociliary clearance rates using aerosol probes and radiolabeled aerosol techniques. An additional approach is the use of nasal masks or mouthpiece exposures of individual subjects in place of an exposure chamber. These design features affect and often determine the technologic and methodologic approaches used for pollutant-generated monitoring and quantitative sampling (1) .
There is a major difference with regard to pollutant generation requirements between studies utilizing facemask or mouthpiece exposures and those conducted in relatively large environmental chambers. With the mouthpiece, a pollutant-air mixture must be produced that only slightly exceeds the individual subject's respiratory intake requirements, e.g., from 5 L min-1 to 50 L min-1 with exercise. In contrast, for chambers operating with a single pass (no recirculation), 5 to 25 m3 min-1 is the likely flow rate requirement, i.e., as much as 1,000 times greater. Usually the exposure duration required for this greater generation capacity is also longer with chamber studies than with mouthpiece or facemask studies.
Monitoring devices are used to determine whether exposure Healthy subjects experienced increased responsiveness to carbachol following 6-hr exposures to 2.0 ppm NO2, in the absence of changes in lung function (14) . Utell et al. (15) found a relationship between baseline airways responsiveness assessed by carbachol in asthmatic subjects and responsiveness to an inhaled sulfuric acid aerosol. In contrast, airways responsiveness to methacholine was not predictive of the FEV, decrement in response to 03 exposure in either smokers or nonsmokers (16) .
Fiberoptic bronchoscopy. Development of fiberoptic bronchoscopy in the 1970s revolutionized the diagnostic evaluation of patients with pulmonary disease, and this technique is now widely used to sample the respiratory tract for research purposes. Its use in studies of asthma has been reviewed recently (17) . Bronchoscopy was first used by Seltzer and colleagues (18) to detect airway inflammation in response to 03 exposure. Since then, bronchoscopy has allowed investigators to characterize the nature of the airway inflammatory response to single and repeated exposures to 03 in healthy, allergic, and asthmatic subjects (19) (20) (21) (22) . It has been used to study the effects of exposure to many pollutants in addition to 03, including NO2 (23-25), SO2, (26), acid aerosols (27) (28) (29) , and diesel exhaust (30) .
A growing number of techniques have been developed using the access provided by the fiberoptic bronchoscope to sample fluids and cells of the lower airway (Table 1) . Bronchoalveolar lavage (BAL), the serial installation and removal of fluid through a bronchoscope wedged in a distal airway, has provided an opportunity to sample the epithelial lining fluid and cells of the distal airways. Evidence suggests that cells recovered by BAL reflect those present in the pulmonary parenchyma in disease states such as sarcoidosis and idiopathic pulmonary fibrosis (31) . However, cells from the pulmonary interstitium, some of which may have a key role in the pulmonary immune response (32) , are not sampled using this technique. A modification of the original technique of serial instillation of aliquots of saline involves separate analysis of the first returned portion of fluid, which preferentially samples the distal conducting airways in which the bronchoscope is wedged. Fluid obtained from subsequent aliquots more closely reflects alveolar sampling (33) . This concept of regional lavage was extended with the use of proximal airway lavage (34) , in which a catheter with two inflatable balloons and a port between them is inserted through the bronchoscope into a mainstem bronchus. The balloons are inflated to isolate the bronchus, and repeated small-volume washes are performed using the port between the balloons. Care must be taken during the procedure to avoid prolonged balloon inflation, as some subjects may experience significantly decreased arterial oxygen tension during occlusion of the airway. The technique has been used successfully in both healthy volunteers and subjects with mild asthma (35) . A modification of this technique has been used to study the effects of 03 exposure in healthy and asthmatic subjects (36) . However, this technique is not often used because of its increased complexity and variability as well as difficulty in interpreting the findings.
The fiberoptic bronchoscope has been used to instill particles into a single subsegmental airway in human subjects to examine localized epithelial responses in an isolated lung region (36 (37) .
Endobronchial biopsy should not be confused with transbronchial biopsy, a procedure designed to obtain alveolar tissue from the human lung for clinical diagnostic purposes. The biopsy forceps are advanced into (38) .
Sputum induction. In recent years, sputum induction has emerged as a research tool for sampling the cells and epithelial lining fluid of the lower respiratory tract in humans (39, 40) . Sputum can be reliably induced in asthmatic subjects as well as in most healthy subjects using nebulized 3-5% saline. The cells recovered are representative of the lower airways and provide a measure of airway inflammation. Asthmatic subjects have more eosinophils and polymorphonuclear leukocytes (PMNs) in sputum than healthy subjects. Sputum inflammatory cells increased with asthma exacerbations (41.42) and allergen challenge (43) , and decreased with prednisone therapy (44) . The results appear to be qualitatively similar to findings in the first (bronchial) aliquot of BAL fluid (45) .
The process of sputum induction itself appears to induce a mild airway inflammatory response. For example, when two inductions are performed 24 hr apart, the second induction has a higher recovery of PMNs (46, 47 (59) . NO levels increase further with clinical exacerbations, correlate with the degree of airway hyperresponsiveness in steroid-naive asthmatics (60) , and decrease following therapy with corticosteroids (61, 62) . A preliminary report (63) indicates that exhaled NO is increased in healthy subjects following exposure to 0.25 ppm 03 2 hr daily for 3 days, suggesting NO may prove to be a useful marker of pollutantinduced inflammation. However, the high concentrations of NO found in the pharynx and nasal passages can confound the measurement of NO production by the lower airways. Furthermore, the lungs have a very high diffusing capacity for NO, and most studies have not taken into account the removal of NO from the airways by capillary blood (64) . (68) used pulse oximetry to study panels of elderly subjects residing at elevation. They found no changes in oxygen saturation, but there were small but significant increases in heart rate associated with outdoor particle concentrations. A 100-pg/m3 increase in the previous-day level of particulate matter < 10 pm in diameter (PM1O) was associated with a 95% increase in the odds of a 10-beat increase in the heart rate. These observations have intensified efforts to understand the relationship between pollutant exposure and changes in cardiac function.
One tool being used in this effort is continuous cardiac monitoring, or Holter recording. Originally used to identify silent arrhythmias in cardiac patients, cardiac monitoring has revealed that both the pattern of variation in heart rate, or heart rate variability, and the pattern of electrical repolarization of the heart are markers of cardiac health or disease. Decreased heart rate variability as well as abnormalities in the duration, dynamics, and heterogeneity of repolarization are established noninvasive predictors of arrhythmic events in patients with cardiovascular diseases (73) (74) (75) (76) (77) and in healthy subjects (78) . Dispersion of repolarization, a noninvasive electrocardiographic (EKG) measure of spatial heterogeneity of repolarization, was increased in patients with COPD (79), but also in healthy subjects in response to hypoxemia (80) .
These observations suggest that detailed analyses of the continuous ambulatory EKG for specific parameters, including heart rate variability and repolarization, might provide insights into the nature of the cardiac effects of pollutant exposure.
Pharmacokinetics ofInhaled Vapors
Although inhaled chemicals such as NO2, 03, and SO2 may cause direct damage to airway and lung tissue, other vapors diffuse very rapidly from the alveolar spaces, through the lung tissue, and into blood, causing no direct lung injury. CO diffuses into the blood and binds avidly to hemoglobin. Other volatile chemicals are absorbed by inhalation and subsequently cause toxicity at sites distal to the respiratory tract. In addition, with some of these chemicals, it is not the parent compound that is most toxic but the metabolites, which may be more reactive and more damaging to the tissue.
The ultimate objective of many toxicologic studies is to take results from animal studies and attempt to predict or describe expected human responses. Physiologically based pharmacokinetic (PBPK) models are used in an attempt to describe the overall disposition of an inhaled chemical by simulating the uptake, distribution, metabolism, and elimination of the inhaled material (81). The PBPK model is then used in extrapolation between species based on animal scaling techniques. The adequacy of interspecies models should be tested by extrapolating the results of experiments with animal models to humans and comparing them with the relatively limited data available from controlled human exposures.
Although the strengths and limitations of the PBPK approach are beyond the scope of this article, Gargas and Andersen (81) In these studies, 12 healthy subjects inhaled 10 ppm D4 (122 pg/L) or air (control) during a 1-hr exposure via a mouthpiece. Inspiratory and expiratory D4 levels were continuously measured as well as exhaled air and plasma levels before, during, and after exposure. Mean D4 intake was 137 mg, with a mean uptake of 13 mg (intake x deposition fraction). The mean deposition fraction at rest was 13% and with exercise it fell to 7%. Plasma measurements of D4 gave a mean peak value of 79 ng/g and indicated a rapid nonlinear blood dearance. These types of data regarding the mean D4 deposition fraction and uptake are applicable to estimates of exposure from both consumer product use and occupational exposure to D4 vapor.
Subsequent studies using 14C-labeled D4
should allow even better quantitative assessments and detection of metabolites in blood and urine. Comparison with data from ongoing animal studies (84, 85) will allow development of PBPK models for extrapolation to humans. The data from controlled human studies should contribute in a meaningful way to the risk assessment process.
Studying Susceptible Subjects
The concept of susceptibility is highly relevant to public health protection and to the delivery of health care. The United States Clean Air Act (86) mandated that national ambient air quality standards be established to protect the health of all susceptible groups within the population.
There is a high degree of variability in human responses to environmental agents. For example, decrements in FEV1 following 4-hr exposures to 0.22 ppm 03 varied from 0 to more than 50% (Figure 1 ) (16), and yet the determinants of this variability are largely unknown. Some of the known and postulated factors influencing variability in human responses to pollutants are as follows: age, gender, body size, exercise, pre-existing disease, atopy, infection, airway geometry, smoking, pregnancy, exposure history, airways responsiveness, nutritional status, antioxidant vitamin intake, and antioxidant enzyme expression. Variability is generally increased in populations with respiratory disease, especially asthma. Some of the observed variability may be related to the actual dose delivered to the lung epithelium or to the distribution of the inhaled pollutant. For example, retention of insoluble 2 pm particles was increased 50% in subjects with COPD compared with healthy subjects, and the increased deposition correlated with the severity of obstruction (87) . The (19, 35) . Furthermore, the mechanisms by which pollutant exposure contributes to respiratory mortality may differ from those responsible for excess cardiovascular mortality.
An understanding of the mechanisms by which ambient concentrations of pollutants increase mortality will require human clinical studies of susceptible subjects. However, such studies are limited by the special needs and changing health status of the subjects. Increased variability in measured parameters often requires that studies of susceptible subjects have larger numbers of subjects per study group compared with studies of healthy subjects. Medication use may alter responses in some subjects. Measures must be taken to protect the safety of susceptible subjects, who may be more vulnerable to adverse effects or complications from testing procedures or pollutant exposures.
In this section we focus on the increased susceptibility conferred by three chronic conditions: asthma, COPD, and cardiovascular disease. 
Asthma
In clinical studies, asthmatics exhibit exaggerated lung function responses to SO2, acidic aerosols, and in some studies, NO2 and 03. Asthmatics may also experience an enhanced airway inflammatory response to 03. In the laboratory, the most striking effect of acute exposure to SO2 at concentrations of 1.0 ppm or below is the induction of bronchoconstriction in asthmatics after exposures lasting only 5 min (88) . In contrast, inhalation of concentrations in excess of 5.0 ppm causes only small decrements in airway function in normal subjects. Similarly, clinical studies have identified exercising adolescent asthmatics (89) and adult asthmatics (90) as susceptible to sulfuric acid aerosols at high ambient concentrations, levels that do not affect healthy volunteers. Although several controlled human studies have found asthmatics responsive to low levels of NO2, the findings have not been consistent (91) . The conflicting results among these studies are probably related to differences in subject selection and exposure protocols.
A number of epidemiologic studies have suggested that emergency room and hospital visits for asthma are increased on high-03 days. It is therefore surprising that most controlled clinical studies generally have not found striking differences in lung function responses to 03 in asthmatic compared with healthy subjects. Several possible explanations exist. In contrast to studies with healthy volunteers, few studies of asthmatic subjects have been performed using prolonged exposures or repeated daily exposures. Furthermore, few studies with asthmatic subjects have incorporated multiple periods of moderate-to-intense exercise, a factor that contributes to changes in airway function with low-level 03 exposure in healthy volunteers.
One study has addressed some of these issues. Horstman and colleagues (92) exposed 17 subjects with clinically active asthma and 13 healthy subjects to 0.16 ppm 03 for 7.6 hr, with multiple prolonged periods of mild exercise. As shown in Table 2 , asthmatic subjects had significantly larger decrements in FEV1 and in FEV1/FVC, despite occasional use of bronchodilators before and during the exposure. This study suggests that people with clinically active asthma may be at increased risk for bronchoconstriction following prolonged exposures to environmentally relevant concentrations of 03.
Two recent studies suggested that mild asthmatics may experience a neutrophilic airway inflammatory response to 03 exposure that is more intense than in healthy subjects (22, 93) . Recent studies have also shown that, in asthmatics, 03 exposures at concentrations sufficient to induce an airway inflammatory response increase responsiveness to a subsequent allergen challenge (94) . Clinical investigations therefore suggest that the mechanisms for exacerbation of asthma following 03 exposure indude bronchoconstriction, worsening of airway inflammation, and increased responsiveness to allergen challenge.
Asthmatics may also be more sensitive to combinations of pollutants. Frampton et al. (95) examined the effects of prior exposure to low-level sulfuric acid aerosol on the airway response to 03 in healthy and asthmatic subjects. Exposure-response relationships were examined using three levels of 03, 0.08, 0.12, and 0.18 ppm. The exposures were preceded 24 hr earlier by exposure to 100 pg/m3 H2S04 or NaCl aerosol. The acidic aerosol and oxidant exposures were 3 hr in duration. Thirty healthy and 30 allergic asthmatics were studied. The findings revealed an interactive relationship between the 03 exposure concentration and H2S04 or NaCI aerosol preexposure in asthmatics but not in healthy subjects. For the asthmatic subjects, 03 concentration-related differences in lung function were observed with H2S04 preexposure but not with NaCl preexposure. These effects were observed for both FVC 25-to 30-fold (99) . Ambient gases, and particles in the ultrafine size range (< 100 nm diameter) are not concentrated using this methodology.
This instrument has been used to demonstrate effects of ambient particulate matter in animals. For example, Gordon and colleagues (100) exposed rats to concentrated ambient air particles (CAPs) or filtered air for 3 hr, and found a significant but transient increase in circulating PMNs along with small alterations in heart rate associated with CAPs exposure. Godleski and colleagues (72) exposed 12 dogs, 6 of which had surgically placed devices to induce transient coronary occlusions, to CAPs or filtered air on multiple occasions. In the 6 surgically treated dogs, exposure to CAPs was associated with a shortened time to ST elevation and an increased magnitude of ST elevation during coronary occlusion. The implications of these studies for human health remain unclear, and human studies using CAPs are now in progress (101, 102) . The key strength of this technology is the ability to separate particle effects from gaseous pollutant effects in the atmospheric mix. However, there are several potential problems. The actual exposure concentration and partide composition may vary day to day and even hour to hour, depending on changes in outdoor particle levels and sources during the experiment. The limited ability to define the chemistry of the CAPs, and the day-to-day changes in particle composition, introduces an additional element of variability into the experimental design. In addition, the failure to concentrate ambient ultrafine particles may have significance. Animal exposure studies suggest that ultrafine particles have increased potential to induce an airway inflammatory response when compared on an equal mass basis with larger partides, perhaps because of their greater number and surface area (103) . The relative absence of ultrafine particles and gaseous pollutants must be considered when interpreting the results of CAPs studies. Diesel Engine E ust Another approach to the problem of mixtures is illustrated by recent studies of exposure to diesel exhaust. Diesel engines have gained favor in may parts of the world because of reduced operating costs and reduced emissions of CO, CO2, and hydrocarbons, compared with gasoline engines. However, they appear to release greater quantities of fine and ultrafine partides and nitrogen oxides (104 This approach permits careful control of the particle to be tested, and permits precise exposure-response assessments. However, the particle design must be guided by detailed chemical and size characterization of ambient particles and by preliminary animal exposure studies to assure safety.
Our laboratory is using this approach to test the hypothesis that particles in the ultrafine size range have greater potential than larger particles to induce airway inflammation, systemic acute phase responses, and changes in cardiac repolarization. We have developed and tested a facility that permits exposures of humans to ultrafine particles of varying composition and that also permits the quantitative determination of exposure levels, respiratory intakes, and depositions of the aerosol. Using this facility, we have initiated clinical studies of exposure to ultrafine particles in healthy human subjects at rest and exercising (107 reproduced with actual ambient exposures. These approaches will require a new level of collaboration between investigators with expertise in epidemiology and human clinical studies but may provide key clues in our understanding of the mechanisms for susceptibility to pollutant effects.
